跳至主要内容
临床试验/NCT02852993
NCT02852993已完成不适用

Survival After Blood Transfusion in the French Administrative Regions of Burgundy and Franche-Comté

Centre Hospitalier Universitaire de Besancon2 个研究点 分布在 1 个国家目标入组 16,099 人开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16,099
试验地点
2
主要终点
Survival

研究概览

简要总结

Red blood cell transfusion (RBC) is the main symptomatic treatment for severe anemia. RBC transfusion has proven its efficacy regarding mortality and morbidity, but it is not without side effects. The infectious side effects of transfusion are largely considered under control, non-infectious side effects are taking center stage. Seeking explanations for the beneficial and deleterious effects of RBC transfusions is necessary to ensure the safe and optimal use of this precious resource.

The investigators aim to study the impact of donor and RBC characteristics on patient survival.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 and over
  • Erythrocyte Transfusion between 2007 and 2011
  • Performed at the University Hospital of Besançon or Dijon

排除标准

  • Transfusion of any blood product prior to January 1st, 2007

结局指标

主要结局

Survival

时间窗: 12 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验